Biblio

Author Title [ Type(Desc)] Year
Filters: First Letter Of Title is W  [Clear All Filters]
Journal Article
Nakashima Y, Omasa T. What Kind of Signaling Maintains Pluripotency and Viability in Human-Induced Pluripotent Stem Cells Cultured on Laminin-511 with Serum-Free Medium?. Biores Open Access. 2016;5(1):84-93.
Mechlin CW, Kogan BA. What lessons can be learned from testicular histology in undescended testes?. Transl Androl Urol. 2014;3(4):365-369.
Karsten U, Goletz S. What makes cancer stem cell markers different?. Springerplus. 2013;2(1):301.
Visintini C, Palese A. What Nursing-Sensitive Outcomes Have Been Investigated to Date among Patients with Solid and Hematological Malignancies? A Scoping Review. Nurs Rep. 2023;13(3):1101-1125.
Lavazza A. What (or sometimes who) are organoids? And whose are they?. J Med Ethics. 2018.
Chalmers BP, Ledford CK, Statz JM, Mabry TM, Hanssen AD, Abdel MP. What Risks are Associated with Primary THA in Recipients of Hematopoietic Stem Cell Transplantation?. Clin Orthop Relat Res. 2016.
Medinger M, Passweg J. What the internist should know about stem cell transplant in the elderly patient. Eur J Intern Med. 2018.
Wahnschaffe L, Herling M. What to Look Out for when Transplanting T-Cell Prolymphocytic Leukemia. Acta Haematol. 2020:1-3.
Steensma DP, Bolton KL. What To Tell Your Patient With Clonal Hematopoiesis And Why: Insights From Two Specialized Clinics. Blood. 2020.
Chavan ARajendra, Bhullar B-AS, Wagner GP. What was the ancestral function of decidual stromal cells? A model for the evolution of eutherian pregnancy. Placenta. 2016;40:40-51.
Goldstein JM, Wagers AJ. What's in a (Sub)strain?. Stem Cell Reports. 2018;11(2):303-305.
Silvestri NJ, El-Dokla A, Wolfe GI, Lacomis D. What's in the Literature?. J Clin Neuromuscul Dis. 2014;15(4):179-90.
Silvestri NJ, Wolfe GI, Bromberg M, Lacomis D. What's in the Literature?. J Clin Neuromuscul Dis. 2016;17(4):227-238.
Cario H, Lobitz S. [What's new in diagnostics and treatment of hemoglobinopathies?]. Dtsch Med Wochenschr. 2019;144(11):719-723.
Williams AL, Bohnsack BL. What's retinoic acid got to do with it? Retinoic acid regulation of the neural crest in craniofacial and ocular development. Genesis. 2019:e23308.
Sun L, Yang W, Li Y, Shan Q, Ye X, Wang D, Yu K, Lu W, Xin P, Pei Z, et al. A wheat dominant dwarfing line with Rht12 which reduces stem cell length and affects GA synthesis, is a 5AL terminal deletion line. Plant J. 2018.
Islam A, Gallaher DD. Wheat Type (Class) Influences Development and Regression of Colon Cancer Risk Markers in Rats. Nutr Cancer. 2015:1-10.
Wolf D, Mayer K. When and how to "FLAMSA-RIC" in AML?. Eur J Haematol. 2015.
Christopeit M. When is second allogeneic HSCT for relapse of acute leukaemia an option?. Bone Marrow Transplant. 2015.
Ren J, Lin K, Xu J, Lu Q, Luo Y, Lin C, Lu J, Weng Y, Zhang Y, Chen Z, et al. When is the best time and grade to start ruxolitinib in corticosteroid-refractory acute graft-versus-host-disease: A multi-center research. Clin Transplant. 2023:e15195.
Pietrasanta C, Minoia F, Torreggiani S, Ronchi A, Gattorno M, Volpi S, Ceccherini I, Mosca F, Filocamo G, Pugni L. When neonatal inflammation does not mean infection: An early-onset mevalonate kinase deficiency with interstitial lung disease. Clin Immunol. 2019.
Soulier J. When Old Hematopoietic Stem Cells Get DamAged. Cell Stem Cell. 2014;15(4):399-400.
Chaudhury S, Schultz KR. When should a Reduced intensity Conditioning (RIC) Hematopoietic Stem Cell Transplant (HSCT) be Considered in Pediatric CML-CP1?. Transplant Cell Ther. 2022;28(7):347-348.
da Costa CT, de Almeida MR, Ruedell CM, Schwambach J, Maraschin FS, Fett-Neto AG. When stress and development go hand in hand: main hormonal controls of adventitious rooting in cuttings. Front Plant Sci. 2013;4:133.
Silvestre J-S. When the vessels use their brain for therapeutic revascularization. Arterioscler Thromb Vasc Biol. 2014;34(2):237-8.

Pages